|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for FAR2 |
Top |
Phenotypic Information for FAR2(metabolism pathway, cancer, disease, phenome) |
Cancer Description | |
Cancer | CGAP: FAR2 |
Familial Cancer Database: FAR2 |
* This gene is included in those cancer gene databases. |
. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Oncogene 1 | Significant driver gene in |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
Metabolic Pathway Description | |
REACTOME_PEROXISOMAL_LIPID_METABOLISM REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS |
Others | |
OMIM | |
Orphanet | |
Disease | KEGG Disease: FAR2 |
MedGen: FAR2 (Human Medical Genetics with Condition) | |
ClinVar: FAR2 | |
Phenotype | MGI: FAR2 (International Mouse Phenotyping Consortium) |
PhenomicDB: FAR2 |
Mutations for FAR2 |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
Structural Variants in COSMIC: go to COSMIC mutation histogram |
- Statistics for Tissue and Mutation type | Top |
- For Inter-chromosomal Variations |
* Inter-chromosomal variantions includes 'interchromosomal amplicon to amplicon', 'interchromosomal amplicon to non-amplified dna', 'interchromosomal insertion', 'Interchromosomal unknown type'. |
- For Intra-chromosomal Variations |
* Intra-chromosomal variantions includes 'intrachromosomal amplicon to amplicon', 'intrachromosomal amplicon to non-amplified dna', 'intrachromosomal deletion', 'intrachromosomal fold-back inversion', 'intrachromosomal inversion', 'intrachromosomal tandem duplication', 'Intrachromosomal unknown type', 'intrachromosomal with inverted orientation', 'intrachromosomal with non-inverted orientation'. |
Sample | Symbol_a | Chr_a | Start_a | End_a | Symbol_b | Chr_b | Start_b | End_b |
pancreas | FAR2 | chr12 | 29414159 | 29414179 | chr15 | 35485999 | 35486019 | |
pancreas | FAR2 | chr12 | 29457071 | 29457091 | chr12 | 30617190 | 30617210 | |
pancreas | FAR2 | chr12 | 29457071 | 29457091 | chr12 | 30617199 | 30617219 |
cf) Tissue number; Tissue name (1;Breast, 2;Central_nervous_system, 3;Haematopoietic_and_lymphoid_tissue, 4;Large_intestine, 5;Liver, 6;Lung, 7;Ovary, 8;Pancreas, 9;Prostate, 10;Skin, 11;Soft_tissue, 12;Upper_aerodigestive_tract) |
Related fusion transcripts : go to Chitars2.0 |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows FAR2 related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
Other DBs for Structural Variants |
Top |
Copy Number Variations in COSMIC: go to COSMIC mutation CNV/Expr |
Mutation type/ Tissue ID | brca | cns | cerv | endome | haematopo | kidn | Lintest | liver | lung | ns | ovary | pancre | prost | skin | stoma | thyro | urina | |||
Total # sample | 1 | 1 |   |   |   |   |   |   | 3 |   | 2 |   |   | 1 | 1 |   | 1 | |||
GAIN (# sample) | 1 | 1 |   |   |   |   |   |   | 3 |   | 2 |   |   | 1 | 1 |   | 1 | |||
LOSS (# sample) |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
cf) Tissue ID; Tissue type (1; Breast, 2; Central_nervous_system, 3; Cervix, 4; Endometrium, 5; Haematopoietic_and_lymphoid_tissue, 6; Kidney, 7; Large_intestine, 8; Liver, 9; Lung, 10; NS, 11; Ovary, 12; Pancreas, 13; Prostate, 14; Skin, 15; Stomach, 16; Thyroid, 17; Urinary_tract) |
Top |
SNV Counts per Each Loci in COSMIC data: go to COSMIC point mutation |
|
Top |
Somatic Mutation Counts per Tissue in COSMIC data |
Stat. for Non-Synonymous SNVs (# total SNVs=41) | (# total SNVs=22) |
(# total SNVs=6) | (# total SNVs=0) |
Top |
Top 10 SNVs Having the Most Samples in COSMIC data |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
chr12:29450110-29450110 | p.I177fs*8 | 4 |
chr12:29423460-29423460 | p.L26L | 3 |
chr12:29485611-29485611 | p.L446M | 3 |
chr12:29446406-29446406 | p.L121L | 3 |
chr12:29474839-29474839 | p.L413L | 3 |
chr12:29462135-29462135 | p.I247R | 2 |
chr12:29450121-29450121 | p.I178T | 2 |
chr12:29474809-29474809 | p.T403T | 2 |
chr12:29423409-29423409 | p.G9G | 2 |
chr12:29450007-29450009 | p.S140_Q141>K | 2 |
Top |
SNV Counts per Each Loci in TCGA data |
|
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample |   | 2 |   | 6 |   |   | 1 |   | 1 | 1 |   | 12 | 4 |   |   |   | 4 | 7 |   | 10 |
# mutation |   | 2 |   | 6 |   |   | 1 |   | 1 | 1 |   | 14 | 4 |   |   |   | 4 | 7 |   | 14 |
nonsynonymous SNV |   | 1 |   | 5 |   |   |   |   | 1 |   |   | 7 | 1 |   |   |   | 4 | 6 |   | 9 |
synonymous SNV |   | 1 |   | 1 |   |   | 1 |   |   | 1 |   | 7 | 3 |   |   |   |   | 1 |   | 5 |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
Top 10 SNVs Having the Most Samples in TCGA data |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr12:29446285 | p.I380I,FAR2 | 2 |
chr12:29423409 | p.G9G,FAR2 | 2 |
chr12:29423429 | p.T16M,FAR2 | 2 |
chr12:29486610 | p.A81D,FAR2 | 2 |
chr12:29460611 | p.N9H,FAR2 | 1 |
chr12:29464850 | p.V184V,FAR2 | 1 |
chr12:29474843 | p.N332S,FAR2 | 1 |
chr12:29460616 | p.L24L,FAR2 | 1 |
chr12:29469849 | p.A196S,FAR2 | 1 |
chr12:29446289 | p.L334L,FAR2 | 1 |
Other DBs for Point Mutations |
Copy Number for FAR2 in TCGA |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for FAR2 |
Gene Expression in Cancer Cell-lines (CCLE) |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
Differential Gene Expression in Primary Tumors (TCGA) |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
Top |
CNV vs Gene Expression Plot |
* This plots show the correlation between CNV and gene expression. |
Top |
Gene-Gene Network Information |
Co-Expressed gene's network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
ACER1,ACSBG1,AWAT1,AWAT2,C1orf105,CARD18,CYP2F1, CYP3A4,DGAT2,DGAT2L6,ELOVL4,ERGIC2,FA2H,FADS6, FAR2,KRT79,PLA2G2F,PNPLA1,PSAPL1,SOAT1,VSX2 | ADAM2,ALOX15B,APOD,C15orf43,CTNNA2,DHRS2,ELOVL7, ENPP3,EPS8L3,FAR2,HIST1H2AG,HPGD,IDI1,IYD, LST-3TM12,NANOG,RNASE12,SCP2,SERHL,SULT1C3,TMPRSS11F |
A1CF,ABCD3,AGMAT,ALDH2,CASP6,CMAS,FAR2, GGT6,GPA33,GUCY2C,HADH,HOOK1,KLHL8,MAOA, MAPKAPK5,PKP2,SLC35A3,SMAGP,SUCLG2,TMBIM6,TMED5 | ATP8B1,BDH1,C12orf49,MCU,CD24,CKMT1B,CSTF2, DARS2,ESRP1,FAR2,FUT3,GJB2,GOLM1,GOT1, HNRNPAB,MTIF2,AP5M1,NARS,NSF,PGGT1B,TTLL12 |
Co-Expressed gene's Protein-protein interaction Network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
Interacting Genes (from Pathway Commons) |
Top |
Pharmacological Information for FAR2 |
There's no related Drug. |
Top |
Cross referenced IDs for FAR2 |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |